This tiny tech stock is racing towards 1,000% gains

I want to tell you about a $4 stock on the path to 1,000% gains. [Money and Markets AM Edition Email Header] Our mission is to help you conquer the markets, so when we see something that we think will help you do that ... we pass it along (even if their opinion is different than our own). Check out the below opportunity from RiskHedge ... we know you’ll like it. --------------------------------------------------------------- Dear Loyal Reader, I want to tell you about a $4 stock on the path to 1,000% gains. It’s a [tiny tech stock]( that 99% of investors have never heard of. But Bill Gates calls its tech breakthrough “the next big thing” in computing. The FDA agrees and has fast-tracked the new technology for approval. I’ve seen stocks soar 10 times or more on FDA approval. So you must act now to get in before any FDA announcement - which could come any day. [Click here to get the details]( on this little-known stock. This is your chance to get in before the FDA gives it the go-ahead and it becomes a household name. By the time you hear about this one on CNBC or Fox Business, it will be too late. Don’t miss this. [Just go here]( for the details on this explosive opportunity. Sincerely, Stephen McBride Chief Analyst, RiskHedge ---------------------------------------------------------------  Privacy Policy The Money & Markets, P.O. Box 8378, Delray Beach, FL 33482. To ensure that you receive future issues of Money & Markets, please add info@mb.moneyandmarkets.com to your address book or [whitelist]( within your spam settings. For customer service questions or issues, please contact us for assistance. The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: [( If you're enjoying your subscription to Money & Markets, leave us a review on Get Financial Reviews by [clicking here](. Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Money & Markets expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Money & Markets, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail. (c) 2020 Money & Markets. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 800-684-8471) Remove your email from this list: [click here to unsubscribe](